GlassScriptPhysician profile
Jared Abraham Morris
NPI 1992952287
$7,831.48
in general payments reported to CMS, 2019-2025
52 companies · $932 in 2025
The $932 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $765 · 2021: $1,090 · 2022: $1,163 · 2023: $1,316 · 2024: $1,708 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,857 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,857.10 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,381.38 | 2021-2025 | |
| Lilly USA, LLC | $575.58 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $569.11 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Astellas Pharma US INC | $518.33 | 2019-2025 | Veozah, Myrbetriq |
| Antares Pharma, INC. | $366.90 | 2020-2024 | Xyosted, Tlando, Nocdurna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $355.92 | 2019-2025 | Xifaxan, Trulance |
| Pfizer INC. | $339.84 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $333.63 | 2019-2024 | Spravato, Xarelto |
| Harmony Biosciences LLC | $317.69 | 2023-2025 | Wakix |
| Supernus Pharmaceuticals, INC. | $296.04 | 2024 | Qelbree, Xyosted |
| Glaxosmithkline, LLC. | $237.69 | 2019-2024 | Trelegy Ellipta, Bexsero, Arexvy |
| Amgen INC. | $217.15 | 2019-2024 | Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $201.45 | 2019-2024 | Trintellix |
| Novo Nordisk INC | $197.55 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $138.75 | 2019-2025 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.